Phenazopyridine Hydrochloride
Product Images NDC 70795-1241

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Phenazopyridine Hydrochloride (NDC 70795-1241). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Graxcell Pharmaceutical, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

01b Lbl_phenazopyridine HCl 100mg_100 Ct_front (01b Lbl Phenazopyridine HCl 100mg 100 Ct Front)

Packaging label for Phenazopyridine Hydrochloride Oral Tablet, USP 100 mg by GRAXCELL PHARMACEUTICAL, LLC. The label includes the NDC 70795-1241, states each tablet contains 100 mg of phenazopyridine HCl, and indicates a package size of 100 tablets. Manufacturing and distribution addresses for the labeler are also shown.*

FDA Label Image

01b Lbl_phenazopyridine HCl 100mg_insert_page_1 (01b Lbl Phenazopyridine HCl 100mg Insert Page 1)

This text panel for Phenazopyridine Hydrochloride Tablets, USP by Graxcell Pharmaceuticals LLC includes a disclaimer about FDA approval status, a caution on prescription requirements, a brief drug description, and the chemical structural formula of phenazopyridine hydrochloride with molecular formula and weight.*

FDA Label Image

01b Lbl_phenazopyridine HCl 100mg_insert_page_2 (01b Lbl Phenazopyridine HCl 100mg Insert Page 2)

This text panel for Phenazopyridine Hydrochloride tablets lists inactive ingredients and provides clinical pharmacology information, including excretion and mechanism of action. It details indications and usage for symptomatic relief of urinary tract discomfort and advises on treatment duration and compatibility with antibacterial therapy. It references a separate dosage and administration section.*

FDA Label Image

01b Lbl_phenazopyridine HCl 100mg_insert_page_3 (01b Lbl Phenazopyridine HCl 100mg Insert Page 3)

This text panel details contraindications, adverse reactions, precautions, and notes for Phenazopyridine Hydrochloride. It includes warnings about hypersensitivity, renal insufficiency, possible side effects such as headache, rash, and gastrointestinal issues, as well as laboratory test interactions and carcinogenesis information.*

FDA Label Image

01b Lbl_phenazopyridine HCl 100mg_insert_page_4 (01b Lbl Phenazopyridine HCl 100mg Insert Page 4)

This text panel provides pregnancy category information, nursing mothers guidance, dosage and administration instructions, and overdose information for Phenazopyridine Hydrochloride. It includes details on reproduction studies, dosing for 100 mg and 200 mg tablets, and symptoms and treatment of overdose.*

FDA Label Image

01b Lbl_phenazopyridine HCl 100mg_insert_page_5 (01b Lbl Phenazopyridine HCl 100mg Insert Page 5)

This text panel details the supply and appearance of Phenazopyridine Hydrochloride 100 mg and 200 mg tablets, noting bottles contain 100 tablets each. The 100 mg tablets are deep brown to maroon, round, film-coated, debossed with "G-15" on one side. The 200 mg tablets share the color and shape but are debossed with "G-17." Storage and dispensing instructions include child-resistant closure and temperature ranges. Manufacturer information for Graxcell Pharmaceuticals LLC is also provided.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.